CIK 0000897448
- Accelerated filer
AMARIN CORP PLC\UK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-12 | THERO JOHN F President and CEO | Sale | −136,422 | $18.05 | $2.5M | 2,565,717 |
| 2018-11-12 | THERO JOHN F President and CEO | Sale | −244,031 | $19.03 | $4.6M | 2,321,686 |
| 2018-11-12 | THERO JOHN F President and CEO | Sale | −222,158 | $19.71 | $4.4M | 2,099,528 |
| 2018-11-12 | THERO JOHN F President and CEO | Sale | −5,000 | $20.72 | $104K | 2,094,528 |
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Sale | −16,542 | $20.72 | $343K | 341,797 |
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Sale | −500 | $21.39 | $11K | 341,297 |
| 2018-10-31 | Kennedy Joseph T General Counsel | Sale | −22,707 | $20.72 | $471K | 218,534 |
| 2018-10-31 | Kennedy Joseph T General Counsel | Sale | −600 | $21.37 | $13K | 217,934 |
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Sale | −116,604 | $17.20 | $2.0M | 341,297 |
| 2018-10-01 | Kennedy Joseph T General Counsel | Sale | −33,049 | $16.33 | $540K | 235,134 |
| 2018-10-01 | Kennedy Joseph T General Counsel | Sale | −8,800 | $17.47 | $154K | 226,334 |
| 2018-10-01 | Kennedy Joseph T General Counsel | Sale | −8,400 | $17.99 | $151K | 217,934 |
| 2018-09-28 | Ketchum Steven B Chief Scientific Officer | Sale | −100,000 | $15.00 | $1.5M | 441,297 |
| 2018-09-28 | Ketchum Steven B Chief Scientific Officer | Sale | −100,000 | $16.00 | $1.6M | 341,297 |
| 2018-09-25 | Ketchum Steven B Chief Scientific Officer | Sale | −100,000 | $13.00 | $1.3M | 441,297 |
| 2018-09-25 | Ketchum Steven B Chief Scientific Officer | Sale | −100,000 | $14.00 | $1.4M | 341,297 |
| 2018-09-24 | Zakrzewski Joseph S Director | Sale | −407,251 | $10.30 | $4.2M | 318,796 |
| 2018-09-24 | Zakrzewski Joseph S Director | Sale | −26,949 | $11.23 | $303K | 291,847 |
| 2018-09-24 | Zakrzewski Joseph S Director | Sale | −65,800 | $12.18 | $801K | 226,047 |
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Sale | −529,791 | $10.04 | $5.3M | 490,747 |
Page 5 of 14 · 279 trades